Post-partum haemorrhage

dhammikesilva 417 views 25 slides Dec 03, 2019
Slide 1
Slide 1 of 25
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25

About This Presentation

An overview of post-partum haemorrhage


Slide Content

Post Partum H aemorrhage Dhammike Silva Senior Lecturer Faculty of Medicine USJP

Primary Loss of 500ml of blood within 24hrs after delivery Major PPH >1000ml Secondary Blood loss greater than expected 24hrs to 12 weeks Definition

Developed countries 5% Sri Lankan 2014 Maternal mortality 113 (MMR 33.7) PPH 11 2015 Maternal mortality 112 (MMR 32.03) PPH 10 Morbidity & near misses are much more higher than mortalities Incidence Family Health Bureau Sri Lanka

TOO LITTLE ….... TOO LATE …... Blood transfusion in PPH

Antenatal diagnosis Oral iron Parental iron Active management of third stage Reducing Risk of BT

CONSENT SAMPLES FOR CROSS MATCHING ABO, Rh D and KELL CMV SERONEGATIVE RED CELL AND PLATELETS – UNIVERSAL LEUCOCYTE DEPLETION GROUP O ,Rh D NEGATIVE ,KELL NEGATIVE

PROPERATIVE/PREDELIVERY AUTOLOGOUS BLOOD DEPOSIT INTRAOPERATIVE CELL SALVAGE MINIMISING USE OF BANKED BLOOD

PROTOCOL SKILLS AND DRILLS MECHANICAL STRATEGIES MANAGEMENT

WHEN ? O , Rh D NEGATIVE WHAT COMPONENTS ?

Ideally same group but others possible 12-15 ml / kg Maintain PT and APTT Regular FBC, and coagulation screen during PPH Cryoprecipitate – standard dose of two 5 unit pools then according to Fibrinogen ( aim at levels > 1.5 g/l ) Fibrinogen 2.9 g / l ( normal 3.5 – 6.5 in pregnancy ) Viral transmission FFP and CRYOPRECIPITATE

Aim Transfusion trigger Ideally Group compatible ABO Non identical possible – HLA matched Anti D P latelets

Initiates blood coagulation Arterial thrombosis No RCT’S in PPH Incidence of Thrombotic complications 2.5 % Recombinant factor VII a

THROMBOELASTOGRAPHY ( TEG) ROTATION THROMBOELASTOMETRY ( ROTEM) VALIDATED TRANSFUSION ALGORITHM PROTOCOL QUALITY ASSURANCE MEASURES NO RCT’s NEAR PATIENT TESTING

No place still Fibrinogen concentrate

Tranexamic Acid Misoprostol Antifibrinolytics and Misoprostol

Aetiology

B Lynch

Airway, breathing, O2 10-15L/min, RR Consciousness Reassurance 14G cannula, Blood 20ml  FBC Coag , cross match Hartmann 2L Colloids 1.5L Blood, FFP, Platelets, Cryoprecipitate Monitoring Oxytocin bolus  infusion Ergometrine bolus PGF2 alpha IM/ direct Tranexemic acid/ Factor VII Foley catheter Misoprostol 1000mg Tone, Trauma, Retained products Uterine massage Communication

Thank you.....